Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

« BIO Europe 2007 | Main | ACE-Inhibitor Hypertensio... »

FDA Approves Neupro Transdermal Patch Against Parkinson's Disease

Filed in archive Drugs, Vaccines and Therapeutics by ruth on May 10, 2007

The US FDA has approved Neupro® (Rotigotine Transdermal System) for the treatment of the signs and symptoms of early-stage idiopathic links

Parkinson's disease (PD). Neupro is a once-daily non-ergolinic dopamine agonist skin patch developed by Schwarz Pharma.

"This is an important step forward for the patients suffering from Parkinson's disease. Following approval and launch within Europe, Neupro will now be available for patients in the USA", comments Iris Loew-Friedrich, MD, PhD,
CSO SCHWARZ PHARMA AG. "We intend to submit a supplemental New Drug Application for the treatment of advanced Parkinson's disease to the FDA by the end of 2007."

Rotigotine is designed to mimic the action of dopamine, a naturally-produced neurotransmitter crucial for proper motor functioning.

Source: Schwarz Pharma (pdf)

Permalink: FDA Approves Neupro Transdermal Patch Against Parkinson's Disease
Tags: FDA Neupro parkinson+disease schwarz+pharma pharma biotech transdermal+patch patch+against

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/68474

Bookmark this entry:

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Transdermal Patch Vaccine Against Alzheimer's Disease - 29 January 2007

Low-Cost Genetic Diagnostic Test for Parkinson's Disease - 23 February 2007

Neupro® (rotigotine transdermal system): First FDA-Approved ... - 10 May 2007

Vote for FDA Approves Neupro Transdermal Patch Against Parkinson's Disease:

Currently 9.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 9.00 out of 1 vote(s) cast.

Add your response to FDA Approves Neupro Transdermal Patch Against Parkinson's Disease: Response from: Edward (05/16/07 11:23am) Very interesting stuff. I have been following this on my blog, http://www.myparkinsonsinfo.com as well. It's very exciting, especially when you take into account the current success Rotigotine is having with Parkinson's patients in the European market. Barring anything unseen, it looks like we'll have the convenience of ONE daily dose by June!!! Response from: Johnson Chen (01/16/08 2:53pm) HealthLat is inviting patients who take Neupro, and physicians who prescribe it to report their experiences with the new drug. Your experiences will help patients needed and make money for you. You are also welcome to check how Neupro has been used by other patients. It is free. For details, please visit: http://www.healthlat.com
Name: *	Email: (will never be shown)*	URL:

(* marked fields are required)
Notify me if more comments appear?	Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).	Remember me
Security Code: * (Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)


We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

RSS	\| See all blog subscribe options
Google	\| What is RSS?
Yahoo!
Addthis
Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts

Contributors (Last 90 days)
Ruth Schaffer (22)
This site has 1274 entries and is powered by Creative Weblogging since July 2005.
Do you want to start or edit an existing blog for us and get paid? More info.
Do you want to advertise on this blog? We have great ideas!
Do you have tips for us? Send them!

Advertise with us
Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.

Testimonials
'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'

Other blogs in the same channel in the Creative Weblogging Network

Health & Life Sciences
Allergies

Daily Power Walk

Daily Diabetic

Straightfromthedoc

Well Woman Blog

Disclaimer
Some of the contents of this site are protected Creative Weblogging Inc. 2004-2009.

Tell a friend about FDA Approves Neupro Transdermal Patch Against Parkinson's Disease
Recipient email:*	Your email:*

(* Both email addresses are required for sending this article. They will never be shown or used for any marketing purposes)
Please enter a message which will be shown together with the article:

Security Code: (Please help us to sort out spam.)

FDA Approves Neupro Transdermal Patch Against Parkinson's Disease

Filed in archive Drugs, Vaccines and Therapeutics by ruth on May 10, 2007

Bookmark this entry:

Related Entries:

Vote for FDA Approves Neupro Transdermal Patch Against Parkinson's Disease:

Add your response to FDA Approves Neupro Transdermal Patch Against Parkinson's Disease:

Tell a friend about FDA Approves Neupro Transdermal Patch Against Parkinson's Disease

Categories

Archives

Our Editors recommend

Contributors (Last 90 days)

Advertise with us

Most popular

Testimonials

Recent Comments

Other blogs in the same channel in the Creative Weblogging Network

Health & Life Sciences

Disclaimer

Find other popular posts from our other blogs:

Well Woman Blog

Daily Diabetic

Daily Power Walk

Straightfromthedoc

Allergies

The Gadgets Weblog